PearsonPSON:LSE

828.50
3.00 / 0.36%
1.79m
38.08 %
0.3999
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of May 27 2016 17:08 BST.

Directors & officers

 NameTitleCompensationAgeOfficer
since
 
SidneyTaurel
Chairman of the Board
--
67
2016
Mr. Sidney Taurel has been appointed as Chairman of the Board of the Company, effective 1 January 2016. Sidney Taurel joined Eli Lilly and Company in 1971 and held management positions in the company's operations in South America and Europe. He was named president of Eli Lilly International in 1986, president of the Pharmaceutical Division in 1993, and chief operating officer in 1996. His 37-year career with the company included 15 years in Brazil, France, Eastern Europe, and the UK. He graduated from École des Hautes Études Commerciales in Paris, France, in 1969. He subsequently received his MBA degree from Columbia University New York, in 1971. An American citizen since 1995, Taurel is fluent in English, French, Spanish and Portuguese. Taurel received three U.S. Presidential appointments: to the Homeland Security Advisory Council (2002-2004), the President's Export Council (2002-2007), and the Advisory Committee for Trade Policy and Negotiations (2007-2009). He is an officer of the French Legion of Honor.
 
JohnFallon
Chief Executive officer, Executive Director
1.45m GBP
53
2013
 
CoramWilliams
Chief Financial Officer
--
41
2015
 
DavidO'Connor
Chief Operating Officer
--
--
2016
 
TomWaldron
Vice President, Investor Relations
--
--
2014
 
StephenJones
Company Secretary
--
--
2016
 
TimScore
Non-Executive Director
--
54
2015
 
ElizabethCorley
Independent Non-Executive Director
--
60
2014
 
VivienneCox
Senior Non-Executive Independent Director
--
56
2012
 
JoshuaLewis
Non-Executive Independent Director
--
52
2011
 
LindaLorimer
Independent Non-Executive Director
--
62
2013
 
HarishManwani
Non-Executive Independent Director
--
63
2013
 
LincolnWallen
Non-Executive Independent Director
--
--
2016
View all 13 directors & officersOfficers and Directors data as of May 28 2016

Director dealings

Directors have sold an average of -44.75k shares during each of the last thirty-six months. Director sales are not usually meaningful unless they are significantly larger than normal.

As of 01 May 2016
Mouseover chart for details.
Dealing dateName & titleSharesPer share (GBX)Deal size (GBP)
Purchase
31 Mar 2016
Ms. Elizabeth P L Corley CBE
677893.006.05k
Purchase
31 Mar 2016
Linda K Lorimer
329878.162.89k
Purchase
31 Mar 2016
Mr. T Score
1,554893.0013.88k
Purchase
31 Mar 2016
Mr. H Manwani
366893.003.27k
Purchase
31 Mar 2016
J Lewis
331878.162.91k
1-5 of 15 results
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.